These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8388182)

  • 1. Centers for Disease Control programs in flow cytometric immunophenotyping.
    Gerber AR
    Ann N Y Acad Sci; 1993 Mar; 677():40-2. PubMed ID: 8388182
    [No Abstract]   [Full Text] [Related]  

  • 2. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%.
    Gelman R; Wilkening C
    Cytometry; 2000 Feb; 42(1):1-4. PubMed ID: 10679736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control in immunophenotyping. Use of human CD4+ and CD8+ T clones as standards.
    Kunkl A; Valle MT; Fenoglio D; Manca F
    Ann N Y Acad Sci; 1993 Mar; 677():417-9. PubMed ID: 8494229
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of clinical standards for flow cytometry.
    Schwartz A; Fernández-Repollet E
    Ann N Y Acad Sci; 1993 Mar; 677():28-39. PubMed ID: 8388180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study.
    Gratama JW; Kraan J; Van den Beemd R; Hooibrink B; Van Bockstaele DR; Hooijkaas H
    Cytometry; 1997 Aug; 30(4):166-77. PubMed ID: 9298834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increase of circulating CD3+CD4-CD8-CD19+ cells in the latent phase of HIV-1 infection].
    Nozaki-Renard J; O'Leary J; Zolla-Pazner S; Tada T
    C R Seances Soc Biol Fil; 1998; 192(5):1007-15. PubMed ID: 9871812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined HIV-1 protein bead array for serology assay and T-cell subset immunophenotyping with a hybrid flow cytometer: a step in the direction of a comprehensive multitasking instrument platform for infectious disease diagnosis and monitoring.
    Faucher S; Martel A; Sherring A; Bogdanovic D; Malloch L; Kim JE; Bergeron M; Sandstrom P; Mandy FF
    Cytometry B Clin Cytom; 2006 May; 70(3):179-88. PubMed ID: 16615079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a universal template for single-platform absolute T-lymphocyte subset enumeration.
    Bergeron M; Faucher S; Ding T; Phaneuf S; Mandy F
    Cytometry; 2002 Apr; 50(2):62-8. PubMed ID: 12116347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there differences between laboratories that use or fail to use the CDC's guidelines to measure CD4+ and CD8+ T cells?
    Ferbas J; Logar AJ; Harwell TS
    Cytometry; 1995 Sep; 22(3):256-7. PubMed ID: 8556958
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program.
    Gelman R; Cheng SC; Kidd P; Waxdal M; Kagan J
    Clin Immunol Immunopathol; 1993 Feb; 66(2):150-62. PubMed ID: 7680972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
    Nicholson JK
    Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy.
    Brando B; Sommaruga E
    Cytometry; 1993; 14(3):294-306. PubMed ID: 8472606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
    Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
    Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Jan; 46(RR-2):1-29. PubMed ID: 9011774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey.
    Homburger HA; Rosenstock W; Paxton H; Paton ML; Landay AL
    Ann N Y Acad Sci; 1993 Mar; 677():43-9. PubMed ID: 8494233
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing.
    Rickman WJ; Monical C; Waxdal MJ
    Ann N Y Acad Sci; 1993 Mar; 677():53-8. PubMed ID: 8494246
    [No Abstract]   [Full Text] [Related]  

  • 17. Automation for clinical CD4 T-cell enumeration, a desirable tool in the hands of skilled operators.
    Diallo TO; Bergeron M; Seely P; Yang X; Ding T; Plews M; Sandstrom P; Ball TB; Meyers AFA
    Cytometry B Clin Cytom; 2017 Nov; 92(6):445-450. PubMed ID: 26990810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HIV-1 infection and cigarette smoking on leukocyte profile in homosexual men.
    Park LP; Margolick JB; Giorgi JV; Ferbas J; Bauer K; Kaslow R; Muñoz A
    Ann N Y Acad Sci; 1993 Mar; 677():433-6. PubMed ID: 8494235
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of quality control procedures in clinical flow cytometry.
    Muirhead KA
    Ann N Y Acad Sci; 1993 Mar; 677():1-20. PubMed ID: 8494200
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease.
    Giorgi JV
    Ann N Y Acad Sci; 1993 Mar; 677():126-37. PubMed ID: 8494202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.